HomeGeneticsConditionCUL3-related neurodevelopmental disorder
Back to Condition
CUL3-related neurodevelopmental disorder
Reviewed by Medicinsk Expert•Last updated: 2026-10-22•Condition

CUL3-related neurodevelopmental disorder

CUL3-related neurodevelopmental disorder is a rare genetic condition that impacts neurological and physical development, often resulting in intellectual disability, learning disorders, and distinct physical features.

Overview

CUL3-related neurodevelopmental disorder affects both neurological and physical development. Children with this condition may experience intellectual disability or specific learning disorders, as well as delays in speech and motor skills, such as sitting and walking. Some individuals may also be diagnosed with autism spectrum disorder, which affects communication and social skills.

Symptoms

The condition presents with a variety of neurological and physical signs:

  • Movement abnormalities: Weak muscle tone (hypotonia) in childhood, progressing to involuntary muscle tensing (dystonia), rhythmic shaking (tremor), or uncontrolled movements (spasms) in adulthood.
  • Distinctive facial features: A long, triangular-shaped face; large forehead; large, rounded nose; small ears; deep-set eyes; or a pointed chin. Some individuals may have a larger than normal head (macrocephaly).
  • Hand and foot abnormalities: Small pinky fingers that curve inward (clinodactyly), narrow thumbs, underdevelopment of the muscle at the base of the thumb (thenar hypoplasia), or a single crease across the palm. Foot issues can include high arches (pes cavus), bunions, fusion of the skin between toes (cutaneous syndactyly), or joint deformities (contractures).
  • Skeletal issues: Abnormally curved lower back (lordosis) or a spine that curves to the side (scoliosis).
  • Other health concerns: Gastroesophageal reflux disease (GERD) in infancy, and rarely, recurrent seizures (epilepsy), congenital heart abnormalities, or genitourinary abnormalities.

Causes

This disorder is caused by variants (mutations) in the CUL3 gene, which provides instructions for making the cullin-3 protein. This protein is essential to the ubiquitin-proteasome system, the cell's quality control mechanism that degrades unwanted, damaged, or misshapen proteins.

When CUL3 variants lead to nonfunctional or absent cullin-3 protein, the ubiquitin-proteasome system fails to break down proteins at the correct time. This leads to an accumulation of unnecessary proteins that interfere with normal cell function. Because cullin-3 is produced in nerve cells throughout the brain, this dysfunction is believed to damage nerve cells, resulting in the signs and symptoms of the disorder.

Inheritance

This condition is inherited in an autosomal dominant pattern, meaning one copy of the altered gene in each cell is sufficient to cause the disorder. Most cases result from new (de novo) variants that occur during the formation of reproductive cells or in early embryonic development, meaning there is typically no family history of the disorder.

Frequently Asked Questions

Early intensive intervention is key. Speech‑language pathology focused on augmentative communication (picture boards or speech‑generating devices) combined with oral‑motor exercises can accelerate speech. For motor skills, a multidisciplinary program that includes physical therapy for strength and balance, occupational therapy for fine‑motor tasks (especially thumb and hand shaping), and regular gait analysis helps address hypotonia and later dystonia. Starting before age 3 yields the most measurable gains.
Even though seizures are rare, obtain a baseline EEG and consider a repeat if new episodes occur. Keep a seizure diary noting triggers, duration, and recovery. If a seizure lasts > 5 minutes or multiple seizures occur without full recovery, call emergency services. Discuss with the neurologist whether a low‑dose antiepileptic (e.g., levetiracetam) is warranted, and ensure the child avoids fever and sleep deprivation, which can lower the seizure threshold.
Baseline cardiac echocardiogram and renal ultrasound are recommended by age 1. If results are normal, repeat cardiac evaluation every 2–3 years and renal imaging every 3–5 years, or sooner if symptoms such as hypertension, edema, or abnormal urinalysis appear. Annual blood pressure checks and urine dipsticks are practical bedside tools.
CUL3‑related disorder follows an autosomal‑dominant pattern with many cases arising from de novo mutations; however, if a pathogenic variant is identified in the affected child, parental testing determines if a parent is a carrier (often mosaic). If a parent carries the variant, each pregnancy has a 50 % risk. Prenatal testing (CVS or amniocentesis) for the known variant, or pre‑implantation genetic testing with IVF, can be offered. Genetic counseling should be arranged to discuss these options.
Source: MedlinePlus, National Library of Medicine

MedlinePlus brings together authoritative health information from the National Library of Medicine (NLM), the National Institutes of Health (NIH), and other government agencies and health-related organizations.

kontakt@hittavard.se

Ⓒ 2024. Alla rättigheter förbehålls av juxt ab

Sök
Om ossVillkor och policyVanliga frågorKontakta oss